5Alderson P,Green S,Higgins J.Cochrane Reviewers’Handbook 4.2.3[Updated November 2004][M/OL].The Cochrane collaboration,[2011-10-18].www.stirrhs.ca/files/handbook.pdf.
6Grander D.How does interferon-alpha exert its antitumour activity inmultiple myeloma?[J].Acta Oncol,2000,39(7):801-805.
7Xu D,Erickson S,Szeps M,et al.Interferon alpha down-regulatestelomerase reverse transcriptase and telomerase activity in hum anmalignant and nonmalignant hematopoietic cells[J].Blood,2000,96(13):4313-4318.
8Chiron D,Pellat-Deceunynck C,Amiot M,et al.TLR3 ligandinduces NF-{kappa}B activation and various fates of multiplemyeloma cells depending on IFN-{alpha}production[J].J Immunol,2009,182(7):4471-4478.
9Ahre A,Bj rkholm M,Mellstedt H,et al.Human leukocyteinterferon and intermittent high-dose melphalan-prednisoneadministration in the treatment of multiple myeloma:a randomizedclinical trial from the Myeloma Group of Central Sweden[J].Cancertreat Rep,1984,68(11):1331-1338.
10Coldmaeher VS,Bourret LA,Levine BA,et al.38</sub> -blocked ricin: an immunotoxin for ?the treatment of multiple myeloma&sid=Blood&aufirst=Coldmaeher VS');
 ">Anti-CD<sub>38</sub> -blocked ricin: an immunotoxin for ?the treatment of multiple myeloma. Blood . 1994
